Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, Morrish E, Venkatasubramani AV, Cernilogar FM, van Heijster FHA, Hundshammer C, Schneider H, Konstantinidis F, Gabler JV, Klement C, Kurniawan H, Law C, Lee Y, Choi S, Guitart J, Forne I, Giustinani J, Müschen M, Jain S, Weinstock DM, Rad R, Ortonne N, Schilling F, Schotta G, Imhof A, Brenner D, Choi J, Ruland J. Wartewig T, et al. Among authors: schneider h. Nat Cancer. 2023 Oct;4(10):1508-1525. doi: 10.1038/s43018-023-00635-7. Epub 2023 Sep 18. Nat Cancer. 2023. PMID: 37723306 Free PMC article.
ANTIVIRAL ACTIVITY OF GLIOTOXIN AND GLIOTOXIN ACETATE.
RIGHTSEL WA, SCHNEIDER HG, SLOAN BJ, GRAF PR, MILLER FA, BARTZ OR, EHRLICH J, DIXON GJ. RIGHTSEL WA, et al. Among authors: schneider hg. Nature. 1964 Dec 26;204:1333-4. doi: 10.1038/2041333b0. Nature. 1964. PMID: 14254440 No abstract available.
Impact of confirmatory test results on subtype classification and biochemical outcome following unilateral adrenalectomy in patients with primary aldosteronism.
Daneshpour H, Brüdgam D, Stüfchen I, Heinrich DA, Bidlingmaier M, Beuschlein F, Kürzinger L, Williams TA, Reincke M, Schneider H, Adolf C. Daneshpour H, et al. Among authors: schneider h. Front Endocrinol (Lausanne). 2024 Nov 29;15:1495959. doi: 10.3389/fendo.2024.1495959. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39678193 Free PMC article.
Corrigendum to "Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess" [Atherosclerosis 398 (2024) 118591].
Meng Y, Bilyal A, Chen L, Mederos Y Schnitzler M, Kocabiyik J, Gudermann T, Riols F, Haid M, Marques JG, Horak J, Koletzko B, Sun J, Beuschlein F, Heinrich DA, Adolf C, Reincke M, Schneider H. Meng Y, et al. Among authors: schneider h. Atherosclerosis. 2024 Dec 6;401:119071. doi: 10.1016/j.atherosclerosis.2024.119071. Online ahead of print. Atherosclerosis. 2024. PMID: 39644614 Free article. No abstract available.
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults.
Clayton-Chubb D, Roberts SK, Majeed A, Woods RL, Tonkin AM, Nelson MR, Chan AT, Ryan J, Tran C, Hodge A, Lubel JS, Schneider HG, Brodtmann A, Fitzgerald SM, Orchard SG, McNeil JJ, Kemp WW. Clayton-Chubb D, et al. Among authors: schneider hg. Geroscience. 2024 Nov 28. doi: 10.1007/s11357-024-01435-2. Online ahead of print. Geroscience. 2024. PMID: 39607592
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
Statistical analysis plan for the FiO2-C trial: effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcomes of extremely preterm infants-a randomized-controlled parallel group multicentre trial for safety and efficacy.
König J, Stauch A, Engel C, Urschitz MS, Franz AR; FiO2-C study group. König J, et al. Trials. 2024 Nov 12;25(1):756. doi: 10.1186/s13063-024-08615-7. Trials. 2024. PMID: 39533330 Free PMC article.
3,924 results